ArticleThe Prostate2026
A Simple Cell Culture Assay for Human Prostatic Branching Morphogenesis Spotlights Bone Morphogenetic Protein Signaling as a Therapeutic Target in Benign Prostatic Hyperplasia.
Article in The Prostate, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundBenign prostatic hyperplasia (BPH) leads to prostate enlargement and lower urinary tract symptoms that can resist treatment. A histologic hallmark of BPH is glandular epithelial hyperplasia with new ductal branching morphogenesis. The stromal inductive factors driving tissue morphogenesis may provide new therapeutic targets, but are incompletely known due in part to a paucity of cell culture model systems. We thus sought to create a reliable cell culture assay for human prostatic branching morphogenesis.
methodsVarious combinations of input cells, cell densities and cell culture medium were trialed. A robust solution comprised embedding BHPrE1 immortalized human prostatic epithelial cells in Matrigel, together with an inductive source of BPH stromal fibroblasts or their conditioned medium. Resultant spheroids were measured and budding/branching morphogenesis evaluated by brightfield microscopy and optionally immunofluorescence. Candidate paracrine signaling pathways were interrogated using small molecule inhibitors and neutralizing antibodies.
resultsWe have detailed a simple, robust cell culture assay for human prostatic epithelial branching morphogenesis. Preliminary application of the assay to investigate signaling pathways previously implicated in developmental budding/branching morphogenesis identified functions of epidermal growth factor (EGF), insulin-like growth factors (IGFs), and bone morphogenetic proteins (BMPs) in stimulating prostatic spheroid growth. However, only BMP inhibition blocked prostatic epithelial budding/branching morphogenesis.
conclusionsWe have described a straightforward cell culture assay for human prostatic budding/branching morphogenesis that in particular spotlights IGFs and BMPs as candidate therapeutic targets in BPH. Additional preclinical testing is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.